教員別検索 - 服部　文幸

資格・免許

職歴(略歴)

所属学会等

学術雑誌掲載論文

学会発表

研究資金受入れ状況

受賞履歴

（最終更新日：2026-09-18 05:05:06.180054）

  ハットリ　フミユキ   HATTORI FUMIYUKI
  服部　文幸
   所属   医学部iPS・幹細胞再生医学講座

職種研究教授

■ 資格・免許

理学博士

■ 職歴(略歴)

1.	1997/04～2007/03	サントリー株式会社医薬事業部
2.	2007/04～2018/03	第一三共株式会社
3.	2018/04～2018/06	学部医学部 ―
4.	2018/06～2028/03	学部医学部研究教授

■ 所属学会等

2011/04～

日本再生医療学会

■ 学術雑誌掲載論文

1.	原著(症例報告除く)	Generation of functional mesothelial cells from human iPSCs that restore peritoneal integrity in experimental peritoneal injury. 2026/04
2.	原著(症例報告除く)	Correlation of Interferons and Autoimmune Aspects in Long COVID-19 Patients 2025/05
3.	原著(症例報告除く)	Expression of genes involved in thyroid hormone action in human induced pluripotent stem cells during differentiation to insulin-producing cells: Effects of iopanoic acid on differentiation 2025/04
4.	原著(症例報告除く)	The role of glial cells missing 2 in induced pluripotent stem cell parathyroid differentiation 2025/02
5.	原著(症例報告除く)	Establishment and characterization of an induced pluripotent stem cell line from a Japanese cystic fibrosis patient with homozygous 1540del10 CFTR mutation 2024/12
6.	原著(症例報告除く)	Lgr6-expressing functional nail stem-like cells differentiated from human-induced pluripotent stem cells 2024/05
7.	原著(症例報告除く)	Application of Live Mitochondria Staining in Cell-Sorting to Purify Hepatocytes Derived from Human Induced Pluripotent Stem Cells 2023/12
8.	原著(症例報告除く)	Efficient protocol for the differentiation of kidney podocytes from induced pluripotent stem cells, involving the inhibition of mTOR 2023/11
9.	原著(症例報告除く)	The induction of parathyroid cell differentiation from human induced pluripotent stem cells promoted via TGF-α/EGFR signaling 2023/11
10.	原著(症例報告除く)	A Novel Cell Injection Method with Minimum Invasion 2023/04
11.	原著(症例報告除く)	Human Induced Pluripotent Stem Cell-Derived KeratinocyteLike Cells for Research on Protease-Activated Receptor 2 in Nonhistaminergic Cascades of Atopic Dermatitis 2023/02
12.	原著(症例報告除く)	Compact automated culture machine for human induced pluripotent stem cell maintenance and differentiation 2022/11
13.	症例報告	Possible internal viral shedding and interferon production after clinical recovery from COVID-19: Case report 2022/08
14.	総説	ミトコンドリア量とALCAMの組み合わせによるヒト多能性幹細胞由来肝細胞の精製法 2021/10
15.	原著(症例報告除く)	Hepatocyte-like cells derived from human pluripotents stem cells can be enriched by combination of mitochondorial content and activated leukocyte cell adhesion molecule. 2019/09
16.	原著(症例報告除く)	"All-in-one"in vitro selection of collagen-binding vascular endothelial growth factor. 2018/04
17.	原著(症例報告除く)	Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells 2016/04
18.	原著(症例報告除く)	Analysis of cardiomyocyte movement in the developing murine heart. 2015/09
19.	原著(症例報告除く)	Time-lapse imaging of cell cycle dynamics during development in living cardiomyocyte. 2014/07
20.	原著(症例報告除く)	Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. 2013/01
21.	原著(症例報告除く)	Distinct iPS Cells Show Different Cardiac Differentiation Efficiency. 2013
22.	症例報告	Disease characterization using LQTS-specific induced pluripotent stem cells. 2012/09
23.	その他	Extracellular cyclophilin A as a humoral factor modulating cardiovascular inflammatory responses. 2012/07
24.	原著(症例報告除く)	Strategies for replacing myocytes with induced pluripotent stem in clinical protocols. 2012/07
25.	原著(症例報告除く)	Wnt2 accelerates cardiac myocyte differentiation from ES-cell derived mesodermal cells via non-canonical pathway. 2012/03
26.	原著(症例報告除く)	Ligand specificity determined by differentially arranged common ligand-binding residues in bacterial amino acid chemoreceptors Tsr and Tar. 2011/12
27.	原著(症例報告除く)	G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation. 2011/04
28.	原著(症例報告除く)	Simple autogeneic feeder cell preparation for pluripotent stem cells. 2011/01
29.	その他	CD117, adult cardiac stem cell marker, is transiently expressed in methothelial epicardial cells. 2010/11
30.	原著(症例報告除く)	Zac1 is an essential transcription factor for cardiac morphogenesis. 2010/04
31.	原著(症例報告除く)	G-CSF promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. 2010/03
32.	原著(症例報告除く)	Strategies for ensuring that regenerative cardiomyocytes function properly and in cooperation with the host myocardium. 2010/03
33.	原著(症例報告除く)	Nongenetic method for purifying stem cell-derived cardiomyocytes. 2010/01
34.	原著(症例報告除く)	Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. 2009/11
35.	原著(症例報告除く)	In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. 2009/08
36.	原著(症例報告除く)	Common marmoset embryonic stem cell can differentiate into cardiomyocytes. 2008/05
37.	原著(症例報告除く)	Sema3a maintains normal heart rhythm through sympathetic innervation patterning. 2007/05
38.	原著(症例報告除く)	Peroxiredoxins in the central nervous system. 2007
39.	原著(症例報告除く)	E-cadherin-coated plates maintain pluripotent ES cells without colony formation. 2006/12
40.	原著(症例報告除く)	Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. 2006/04
41.	その他	Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. 2005/05
42.	原著(症例報告除く)	Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. 2003/08
43.	原著(症例報告除く)	Shikonin stimulates glucose uptake in 3T3-L1 adipocytes via an insulin-independent tyrosine kinase pathway. 2002/04
5件表示
全件表示(43件)

■ 学会発表

1.	A novel cell injection device （口頭） 2025/11/21
2.	A novel cell injection device （口頭，一般） 2025/11/20
3.	A novel cell injection device （口頭） 2025/11/19
4.	Fingertip Regeneration Therapy （口頭，特別講演・招待講演など） 2025/10/29
5.	Fingertip Regeneration Therapy （ポスター掲示） 2025/10/01
6.	Technological Developments From Heart to Fingertip Regenerative Therapies using Human-Induced Pluripotent Stem Cells and the Importance of Automated Culture Systems. （口頭，特別講演・招待講演など） 2025/10/01
7.	SLE関連マーカーとIFNプロファイルより自己免疫的背景が示唆されたCOVID-19罹患後症状患者の1例（口頭，一般） 2025/09/20
8.	放射線治療による唾液腺萎縮に対するヒトiPS細胞を用いた細胞移植療法の基礎的研究（ポスター掲示，一般） 2023/11/12
9.	放射線治療よる唾液腺機能不全に対するヒトiPS細胞を用いた細胞移植療法（口頭，一般） 2022/03/23
10.	イノベーション再生医学は何をする人ぞ（口頭） 2021/11/17
11.	ヒトiPS細胞由来肝細胞の純化法の開発（口頭，シンポジウム・ワークショップパネル（指名）） 2020/08/27
12.	放射線治療による唾液腺機能不全に対するヒトiPS細胞を用いた細胞移植法（口頭，一般） 2020/05/18
13.	CRISPR/Cas9 システムを用いたヒト造血幹細胞におけるCD34抗原の発現意義の解析（ポスター掲示，一般） 2019/03/21
5件表示
全件表示(13件)